Work

Phase I/II Trial of High-Dose Melphalan (M) and Topotecan (T) Followed by Autologous Stem Cell Rescue in Patients ≤ 60 and > 60 Years of Age with Multiple Myeloma (MM).

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.943.943

Authors: Daniel Sullivan, Melissa Alsina, Claudio Anasetti, Teresa Field, Mohamed Kharfan-Dabaja, Hugo Fernandez, William Dalton, Ernesto Ayala, Jyoti Raychaudhuri, Lia Perez, Janelle Perkins, Michael Schell, Christine McIsaac, Beth Maddox, Jana Gump, Richard Lush, Tony Frudakis

Institution: Moffitt Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2573430370

FWCI:

Cites:

Cited by:

Related to: 10